Form 4: Passage Bio CEO William Chou Acquires 779,533 Stock Options
SEC Form 4 Filing
William Chou, CEO of Passage Bio, Inc., was granted 779,533 employee stock options on March 15, 2025, according to a Form 4 filing with the SEC.
Summary
- William Chou, the President and CEO of Passage Bio, Inc. (PASG), acquired 779,533 employee stock options on March 15, 2025.
- The exercise price of these options is $0.387.
- The options vest monthly, starting April 15, 2025, at a rate of 1/48 of the total shares, contingent upon Chou's continued service to the company.
- The options expire on March 15, 2035.
- Following this transaction, Chou directly owns 779,533 derivative securities.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The granting of stock options is a standard practice and generally viewed as a positive sign of aligning management's interests with shareholders. There are no red flags or negative information in the document.
Positives
- The granting of stock options to the CEO aligns his interests with those of the shareholders, incentivizing him to improve the company's performance.
- The vesting schedule encourages long-term commitment from the CEO.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting schedule of the options.
Industry Context
Stock options are a common form of executive compensation in the biotechnology industry, aligning management's interests with those of shareholders and incentivizing long-term value creation.
Comparison to Industry Standards
- Executive compensation packages, including stock options, are common in the biotech industry.
- Companies like Amgen, Biogen, and Gilead Sciences also utilize stock options as part of their executive compensation plans.
- The specific number of options and vesting schedules vary depending on the company's size, stage of development, and overall compensation strategy.
Stakeholder Impact
- Shareholders: Aligns CEO's interests with shareholder value.
- Employees: May boost morale knowing the CEO is incentivized to improve company performance.
Key Dates
| Date | Description |
|---|---|
| 03/15/2025 | Date of earliest transaction: Grant date of stock options. |
| 03/15/2025 | Transaction Date: William Chou acquired 779,533 employee stock options. |
| 04/15/2025 | Vesting start date: Stock options vest monthly beginning on this date. |
| 03/15/2035 | Expiration Date: Stock options expire on this date. |
| 03/18/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.